» Articles » PMID: 36983805

The Current Strategy in Hormonal and Non-Hormonal Therapies in Menopause-A Comprehensive Review

Abstract

Menopause is a natural stage of hormonal aging in women, accompanied by a series of symptoms that reduce the quality of life of a fully active person. As no therapy is entirely satisfactory, the race for a better option is in full swing. Our study objective is to investigate the most recent menopause studies on pharmacological resources, emerging therapies, and the particularities of hormonal replacement therapy (HRT). For this purpose, a comprehensive search was conducted in two main databases (PubMed and Web of Science) guided by the specific keywords "menopause" and "therapy" or "estrogen" or "progesterone" or "hormone replacement" during the last ten years period. Studies were eligible if they met certain criteria: randomized controlled trials (RCT) in adult women with menopause and hormonal or non-hormonal therapies. We selected 62 RCTs, which are focused on four main topics: (a) epidemiology of menopause-related symptoms, (b) hormonal replacement therapy (HRT) selective estrogen receptor modulators, (c) emerging therapies, and (d) menopause. HRT has proven a real health benefit for menopausal women; besides, complementary interventions must be considered. Further studies are needed on menopause and menopause-related therapies. The continuous updating of clinical experience will strengthen the therapeutic benefit and the decision to treat patients safely. This goal will fully access all therapeutic resources to address an unresolved health issue of active adult women.

Citing Articles

The intersection of aging and estrogen in osteoarthritis.

Atasoy-Zeybek A, Showel K, Nagelli C, Westendorf J, Evans C NPJ Womens Health. 2025; 3(1):15.

PMID: 40017990 PMC: 11860234. DOI: 10.1038/s44294-025-00063-1.


Humic Acid Derived from Vermicompost Improves Bone Mineral Content and Alters Oxidative Stress Markers in Ovariectomized Mice.

Santos T, Silva H, Lima K, Salvador M, Candido G, Pimenta L Biomedicines. 2025; 13(2).

PMID: 40002908 PMC: 11853275. DOI: 10.3390/biomedicines13020495.


QbD-Driven preparation, characterization, and pharmacokinetic investigation of daidzein-l oaded nano-cargos of hydroxyapatite.

Gautam N, Dutta D, Mittal S, Alam P, Emad N, Al-Sabri M Sci Rep. 2025; 15(1):2967.

PMID: 39848966 PMC: 11757988. DOI: 10.1038/s41598-025-85463-8.


Safety of Innovative Nanotechnology Oral Formulations Loaded with Bioactive Menopause Molecules: Influence of Genotoxicity and Biochemical Parameters on a Menopausal Rat Model.

Crisan S, Pop A, Lacatusu I, Badea N, Mustaciosu C, Radu M Nutrients. 2023; 15(23).

PMID: 38068809 PMC: 10708031. DOI: 10.3390/nu15234951.

References
1.
Adelman M, Nygaard I . Time for a "Pause" on the Use of Vaginal Laser. JAMA. 2021; 326(14):1378-1380. DOI: 10.1001/jama.2021.14809. View

2.
Ley S, Li Y, Tobias D, Manson J, Rosner B, Hu F . Duration of Reproductive Life Span, Age at Menarche, and Age at Menopause Are Associated With Risk of Cardiovascular Disease in Women. J Am Heart Assoc. 2017; 6(11). PMC: 5721766. DOI: 10.1161/JAHA.117.006713. View

3.
Ettinger B, Wang S, Leslie R, Patel B, Boulware M, Mann M . Evolution of postmenopausal hormone therapy between 2002 and 2009. Menopause. 2018; 25(11):1306-1312. DOI: 10.1097/GME.0000000000001233. View

4.
Pinkerton J, Harvey J, Lindsay R, Pan K, Chines A, Mirkin S . Effects of bazedoxifene/conjugated estrogens on the endometrium and bone: a randomized trial. J Clin Endocrinol Metab. 2014; 99(2):E189-98. DOI: 10.1210/jc.2013-1707. View

5.
Barnabei V, Cochrane B, Aragaki A, Nygaard I, Williams R, McGovern P . Menopausal symptoms and treatment-related effects of estrogen and progestin in the Women's Health Initiative. Obstet Gynecol. 2005; 105(5 Pt 1):1063-73. DOI: 10.1097/01.AOG.0000158120.47542.18. View